RT Journal Article
SR Electronic
T1 IL-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV (PLWH)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.28.24308045
DO 10.1101/2024.05.28.24308045
A1 Gupta, Akshita
A1 Righi, Elda
A1 Konnova, Angelina
A1 Sciammarella, Concetta
A1 Spiteri, Gianluca
A1 Averbeke, Vincent Van
A1 Berkell, Matilda
A1 Hotterbeekx, An
A1 Sartor, Assunta
A1 Mirandola, Massimo
A1 Malhotra-Kumar, Surbhi
A1 Azzini, Anna Maria
A1 Pezzani, Diletta
A1 Monaco, Maria Grazia Lourdes
A1 Vanham, Guido
A1 Porru, Stefano
A1 Tacconelli, Evelina
A1 Kumar-Singh, Samir
YR 2024
UL http://medrxiv.org/content/early/2024/05/28/2024.05.28.24308045.abstract
AB People living with HIV (PLWH) despite having appreciable depletion of CD4+ T-cell show a good SARS- CoV-2 vaccination response. The underlying mechanism(s) are currently not understood. We studied serological and polyfunctional T-cell responses in PLWH receiving anti-retroviral therapy stratified on CD4+ counts as PLWH-high (CD4 ≥500 cells/μL) and PLWH-low (<500 cells/μL). Responses were assessed longitudinally before the first vaccination (T0), 1-month after the first dose (T1), and 3- months (T2), and 6-months (T3) after the second dose. Expectedly, both PLWH-high and -low groups developed similar serological responses after T2, which were also non-significantly different to age and vaccination-matched HIV-negative controls at T3. The IgG titers were also protective showing a good correlation with ACE2-neutralizations (R=0.628, P=0.005). While no difference at T3 was observed between PLWH and controls in activated CD4+CD154+ and CD4+ memory T-cells, spike- specific CD4+ polyfunctional cytokine expression analysis showed that PLWH preferentially express IL-2 (P<0.001) and controls, IFN-γ (P=0.017). CD4+ T-cell counts negatively correlated with IL-2- expressing CD4+ T-cells including CD4+ memory T-cells (Spearman ρ: -0.85 and -0.80, respectively; P<0.001). Our results suggest that the durable serological and CD4+ T-cell responses developing in vaccinated PLWH are associated with IL-2-mediated CD4+ T-cell activation that likely compensates for CD4+ T-cell depletion in PLWH.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the ORCHESTRA project, which has received funding from the European Unions Horizon 2020 research and innovation program under grant agreement No 101016167.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was obtained from the University Hospital Verona Ethics Board (protocol number: 19293) and conducted in accordance with the Declaration of Helsinki. No study activities took place prior to collection of informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes